Literature DB >> 22068680

Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer.

Christoph Benckert1, Armin Thelen, Thorsten Cramer, Wilko Weichert, Gereon Gaebelein, Reinhard Gessner, Sven Jonas.   

Abstract

PURPOSE: The roles of angiogenesis and the most prominent angiogenic vascular endothelial growth factor (VEGF) in diseases of the pancreas remain controversial. We compared microvessel density (MVD) and VEGF status in normal pancreatic, chronic pancreatic, and pancreatic cancer (PC) tissues to establish their prognostic relevance.
METHODS: Eighty samples of PC tissue, 32 samples of normal pancreatic tissue, and 20 samples of chronic pancreatitis (cP) tissue were immunostained with monoclonal anti-CD31 and polyclonal anti-VEGF antibody. The MVD was correlated with clinicopathological features and survival.
RESULTS: Microvessel density was higher in PC than in cP (P < 0.001). Residual tumor status was highly predictive for survival (P < 0.001). After stratification for residual tumor status, we identified lymph node metastasis (LNM) in more than two lymph nodes (P < 0.04) and high MVD (P < 0.03) as risk factors for mortality. Multivariate analysis revealed only a high MVD (P = 0.03, odds ratio 0.441, 95% confidence interval 0.211-0.821) as an independent predictor of poor survival. Vascular endothelial growth factor was found over stromal cells in cP and over ductal adenocarcinoma cells in PC. Vascular endothelial growth factor expression status was not predictive of survival (P < 0.07).
CONCLUSION: This study confirms the role of angiogenesis in PC and identifies MVD as an independent prognostic factor in patients with curatively resected PC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068680     DOI: 10.1007/s00595-011-0045-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  48 in total

1.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

2.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

3.  Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.

Authors:  Ma Jinfeng; Wataru Kimura; Fumiaki Sakurai; Toshiyuki Moriya; Masaomi Mizutani; Ichiro Hirai
Journal:  Hepatogastroenterology       Date:  2007-09

4.  A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.

Authors:  Richard Kim; Raymond Tsao; Ann Tan; Mike Byrne; Khaldoun Almhanna; Aleksander Lazaryan; Paul Elson; Robert J Pelley
Journal:  J Gastrointest Surg       Date:  2010-05-06       Impact factor: 3.452

5.  The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.

Authors:  Ryan M Thomas; Dawn V Jaquish; Randall P French; Andrew M Lowy
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

6.  Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.

Authors:  S Fujioka; K Yoshida; S Yanagisawa; M Kawakami; T Aoki; Y Yamazaki
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

7.  Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival.

Authors:  Kenichi Kuwahara; Tamito Sasaki; Yukio Kuwada; Masateru Murakami; Souichirou Yamasaki; Kazuaki Chayama
Journal:  Pancreas       Date:  2003-05       Impact factor: 3.327

Review 8.  Evaluation of microvascular density in tumors: pro and contra.

Authors:  Beatrice Nico; Vincenzo Benagiano; Domenica Mangieri; Nicola Maruotti; Angelo Vacca; Domenico Ribatti
Journal:  Histol Histopathol       Date:  2008-05       Impact factor: 2.303

9.  Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.

Authors:  Seiko Hirono; Hiroki Yamaue; Yutaka Hoshikawa; Shinomi Ina; Masaji Tani; Manabu Kawai; Masaru Ushijima; Masaaki Matsuura; Yuriko Saiki; Akio Saiura; Junji Yamamoto; Yoshio Miki; Tetsuo Noda
Journal:  Cancer Sci       Date:  2009-09-10       Impact factor: 6.716

10.  Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Authors:  J Itakura; T Ishiwata; H Friess; H Fujii; Y Matsumoto; M W Büchler; M Korc
Journal:  Clin Cancer Res       Date:  1997-08       Impact factor: 12.531

View more
  14 in total

1.  Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression.

Authors:  Qiubo Zhang; Xuanna Li; Yaqing Li; Shaojie Chen; Xiaoling Shen; Xianwen Dong; Yufei Song; Xuesong Zhang; Kaihong Huang
Journal:  Invest New Drugs       Date:  2019-05-14       Impact factor: 3.850

2.  IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.

Authors:  Song Gao; Yan Sun; Xuebin Zhang; Limei Hu; Yuexin Liu; Corrine Yingxuan Chua; Lynette M Phillips; He Ren; Jason B Fleming; Huamin Wang; Paul J Chiao; Jihui Hao; Wei Zhang
Journal:  Cancer Res       Date:  2016-09-22       Impact factor: 12.701

3.  Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.

Authors:  Lu-Lu Zhai; Yang Wu; Chong-Yang Cai; Zhi-Gang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.

Authors:  Michael Stotz; Joanna Szkandera; Julia Seidel; Tatjana Stojakovic; Hellmut Samonigg; Daniel Reitz; Thomas Gary; Peter Kornprat; Renate Schaberl-Moser; Gerald Hoefler; Armin Gerger; Martin Pichler
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

5.  Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma.

Authors:  Francesco Di Maggio; Prabhu Arumugam; Francesca R Delvecchio; Silvia Batista; Tanguy Lechertier; Kairbaan Hodivala-Dilke; Hemant M Kocher
Journal:  Pancreatology       Date:  2016-06-01       Impact factor: 3.996

6.  Correlation analysis between the parameters of contrast-enhanced ultrasonography in evaluating cervical cancer metastasis and expression of E-cadherin.

Authors:  Xiaolan Lv; Min Hou; Xiaojing Duan
Journal:  Oncol Lett       Date:  2017-08-22       Impact factor: 2.967

7.  Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway.

Authors:  Yongfei Li; Jiahui Chu; Jun Li; Wanting Feng; Fan Yang; Yifan Wang; Yanhong Zhang; Chunxiao Sun; Mengzhu Yang; Shauna N Vasilatos; Yi Huang; Ziyi Fu; Yongmei Yin
Journal:  Mol Oncol       Date:  2018-06-14       Impact factor: 6.603

8.  MACC1 promotes angiogenesis in cholangiocarcinoma by upregulating VEGFA.

Authors:  Tao Peng; Zhonghu Li; Dajiang Li; Shuguang Wang
Journal:  Onco Targets Ther       Date:  2019-03-08       Impact factor: 4.147

9.  The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.

Authors:  Tao Peng; Xiang Deng; Feng Tian; Zhonghu Li; Peng Jiang; Xin Zhao; Guangyu Chen; Yan Chen; Ping Zheng; Dajiang Li; Shuguang Wang
Journal:  Int J Oncol       Date:  2019-07-15       Impact factor: 5.650

10.  RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cells.

Authors:  Changqing Yan; Chuan Wang; Mei Dong; Sanguang Liu; Cheng Qi; Yupei Zhao
Journal:  Oncol Lett       Date:  2013-01-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.